Reuters logo
BRIEF-Interpace Diagnostics announces European patent approval for underlying technology of its thyramir microrna classifier
April 3, 2017 / 12:36 PM / 8 months ago

BRIEF-Interpace Diagnostics announces European patent approval for underlying technology of its thyramir microrna classifier

April 3 (Reuters) - Interpace Diagnostics Group Inc

* Interpace Diagnostics announces European patent approval for underlying technology of its thyramir microrna classifier

* Interpace Diagnostics Group Inc says plans to validate and enforce this intellectual property in select European countries going forward Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below